These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9382038

  • 1. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
    Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordon SC.
    Am J Gastroenterol; 1997 Oct; 92(10):1793-5. PubMed ID: 9382038
    [Abstract] [Full Text] [Related]

  • 2. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL, Izopet J, Galindo-Migeot V, Lauwers-Cances V, Zarski JP, Seigneurin JM, Dussaix E, Voigt JJ, Selves J, Barange K, Puel J, Pascal JP.
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
    Sim H, Yim C, Krajden M, Heathcote J.
    Am J Gastroenterol; 1998 Jan; 93(1):39-43. PubMed ID: 9448171
    [Abstract] [Full Text] [Related]

  • 5. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M, Murai S, Kojima H, Tokita H, Kamitsukasa H, Harada H.
    Hepatogastroenterology; 1999 Jan; 46(26):1094-9. PubMed ID: 10370673
    [Abstract] [Full Text] [Related]

  • 6. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A.
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Yakabi S.
    Hepatogastroenterology; 2003 Dec; 50(49):165-9. PubMed ID: 12630015
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.
    Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH.
    Hepatology; 1998 Oct; 28(4):1121-7. PubMed ID: 9755252
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
    Everson GT, Jensen DM, Craig JR, van Leeuwen DJ, Bain VG, Ehrinpreis MN, Albert D, Joh T, Witt K.
    Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.